Pain Evaluation and Treatment in Clinical Settings
Unknown statusNot applicableNCT05197777
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
This new research projet in pain is enrolled into an international official collaboration between researchers and clinicians from Irmandade da Santa Casa de Londrina (ISCAL) and those from two Quebec universities: University of Quebec in Chicoutimi (UQAC) and University of Quebec in Rimouski (UQAR). ISCAL as a living laboratory research environment (sites, equipment, technology) for researchers, clinicians, students, and patients pool will make this project unique in the world, especially to stablish an integral concept on pain from identification, assessment and management, using neurophysiological central measures across patients with neuromusculoskeletal disorders. ISCAL in partnership with Santa Hospital in Londrina admit so many patients per day suffering of pain, by supporting a specific size of sample for establishment of this integral concept in pain. This project builds on the foundations already well installed at ISCAL for data acquisition and storage, from an ideal set-up including patients with pain and clinicians. ISCAL infrastructure will be used to improve the acquirement of pain data from patients, using high-tech tools in a simple and robust experimental protocol targeting the central nervous system (CNS). Pain conventional evaluation (by questionnaires or simple questions related to pain intensity from anamneses or inspection doctor) will be completed by neurophysiological measures of the CNS activity based on the acquisition of biological signals and related to functional activities of the patients. A specific physiological behavior of pain will be determinate, using different types of preprocessing and statistical analyzes on biological signals. While pain and physical dysfunction mechanisms involve through the CNS, measurements from the CNS will allow to better understand the profiles and needs of the population (active adults and older people) suffering from pain and disabilities. The knowledge acquired throughout this research program will imp…
Study details
- Official title
- Innovations in Pain Assessment and Treatment for Individuals With Musculoskeletal Disorders: Brazil and Canada Collaboration
- Conditions
- Chronic Pain
- Functional Limitations
- Musculoskeletal Disorders
- Interventions
- Device: tDCS associated to functional activities
- Other: Conservative physiotherapy
- Sponsor
- Rubens da Silva
- Collaborators
- Londrina Santa casa Hospital
- Organization
- Université du Québec à Chicoutimi
- Start date
- 2023-11-01
- Primary completion
- 2024-12-31
- Sex
- All
- Age range
- from 20 Years to 85 Years
- Results posted
- No results posted in this snapshot
- Countries
- Brazil
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Adults males and females * Age ≥ 20 years and older (≤ 85) * Body mass index (BMI) between 18 and 35 kg/m2 * From local the community, or be in the waiting list, or be admitted in ISCAL - Irmandande Santa Casa de Londrina (Londrina Santa Casa Hospital) * Present, at least, 1 diagnosis of musculoskeletal disorder (medical diagnosis declared by the doctors of the clinical team of the hospital) * Be able to present to the room and perform the tests and functional tasks, without and with minimal assistance * Present a cognitive state greater than 20 in Mini-Mental State Examination. Exclusion Criteria: * Cancer * Red flags (infection, tumor, etc.) * Severe psychiatric disorders * Palliative care * Congenital spinal deformity (spondylolysis, intervertebral fusions, 4 lumbar vertebrae) * Fairly severe systemic syndromes or diseases that may preclude testing * Stroke - very acute phase (1 week) and this is until medial hemodynamic stability * Any drugs or condition that could affect EEG or rMT measurements
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT05197777